Combining Hematopoietic and Mesenchymal Stem Cells for Better Tissue Repair
Author Information
Author(s): Moioli Eduardo K., Clark Paul A., Chen Mo, Dennis James E., Erickson Helaman P., Gerson Stanton L., Mao Jeremy J.
Primary Institution: Columbia University Medical Center
Hypothesis
Co-transplantation of hematopoietic and mesenchymal stem/progenitor cells improves angiogenesis of tissue repair and hence the outcome of regeneration.
Conclusion
Co-transplantation of hematopoietic and mesenchymal stem/progenitor cells significantly enhances vascularization and tissue regeneration.
Supporting Evidence
- Co-transplantation of CD34+ HSCs and CD34− MSCs resulted in significantly greater vascularization compared to MSC transplantation alone.
- Human osteocalcin expression was significantly increased upon co-transplantation of MSCs and CD34+ cells.
- VEGF delivery further enhanced vascular number and diameter in co-transplanted scaffolds.
Takeaway
This study shows that mixing two types of stem cells can help heal tissues better by making more blood vessels.
Methodology
Hematopoietic and mesenchymal stem/progenitor cells were isolated from human bone marrow and co-transplanted into porous scaffolds implanted in immunocompromised mice.
Potential Biases
Potential bias in the selection of stem cell sources and the experimental model used.
Limitations
The study primarily focused on bone regeneration and may not be generalizable to other tissue types.
Participant Demographics
Three healthy male donors were used for bone marrow samples.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website